When did SEELOS THERAPEUTICS INC (SEEL) report earnings last quarter?
SEELOS THERAPEUTICS INC (SEEL) last reported earnings on 8/2/2024.
NASDAQ:SEEL • US81577F3073
Past quarterly earnings results for SEELOS THERAPEUTICS INC (SEEL), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2024 | -1.21 | - | 81.61% | 376K | 306K | 22.88% | 11.90% | |
| Q1 2024 | -1.51 | - | 58.07% | 579K | 306K | 89.22% | -28.34% | |
| Q4 2023 | -6.32 | -6.53 | 3.19% | -23.92% | 653K | - | - | |
| Q3 2023 | -28.80 | -14.69 | -96.08% | -433.33% | 410K | - | - | |
| Q2 2023 | -6.60 | -2.86 | -131.10% | -3,200.00% | 336K | - | - | |
| Q1 2023 | -3.60 | -3.37 | -6.95% | -2,669.23% | 808K | 204K | 296.08% | - |
| Q4 2022 | -5.10 | -3.98 | -28.21% | -1,721.43% | - | - | ||
| Q3 2022 | -5.40 | -3.21 | -68.07% | -4,809.09% | - | - | ||
| Q2 2022 | -0.20 | -0.15 | -36.80% | -150.00% | - | - | ||
| Q1 2022 | -0.13 | -0.18 | 29.19% | 53.57% | - | - | ||
| Q4 2021 | -0.28 | -0.11 | -149.55% | -115.38% | - | - | ||
| Q3 2021 | -0.11 | -0.09 | -26.87% | -22.22% | - | - | ||
| Q2 2021 | -0.08 | -0.13 | 36.75% | - | - | - | ||
| Q1 2021 | -0.28 | -0.09 | -205.01% | -100.00% | - | - | ||
| Q4 2020 | -0.13 | -0.08 | -59.31% | - | - | - | ||
| Q3 2020 | -0.09 | -0.08 | -10.29% | - | - | - | ||
| Q2 2020 | -0.08 | -0.14 | 41.90% | - | - | - | ||
| Q1 2020 | -0.14 | -0.22 | 37.61% | - | - | - |
Notes
SEELOS THERAPEUTICS INC (SEEL) last reported earnings on 8/2/2024.
SEELOS THERAPEUTICS INC (SEEL) missed EPS estimates and beat revenue estimates in the most recent quarter.